Aspargo Labs, Inc. (AAGO)
Aspargo Labs will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Aspargo Labs Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 9.15 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 73.34 |
Financial Efficiency
Return on equity (ROE) is -130.37% and return on invested capital (ROIC) is -131.50%.
| Return on Equity (ROE) | -130.37% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -131.50% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $9,332 |
| Profits Per Employee | -$2.03M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aspargo Labs had revenue of $102,654 and -$22.36 million in losses.
| Revenue | 102,654 |
| Gross Profit | 51,213 |
| Operating Income | -22.70M |
| Pretax Income | -22.36M |
| Net Income | -22.36M |
| EBITDA | -22.57M |
| EBIT | -22.67M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $18.72 million in cash and $106,315 in debt, giving a net cash position of $18.62 million.
| Cash & Cash Equivalents | 18.72M |
| Total Debt | 106,315 |
| Net Cash | 18.62M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 17.15M |
| Book Value Per Share | n/a |
| Working Capital | -3.93M |
Cash Flow
In the last 12 months, operating cash flow was -$17.42 million and capital expenditures -$125,000, giving a free cash flow of -$17.54 million.
| Operating Cash Flow | -17.42M |
| Capital Expenditures | -125,000 |
| Free Cash Flow | -17.54M |
| FCF Per Share | n/a |
Margins
Gross margin is 49.89%, with operating and profit margins of -22,111.82% and -21,786.08%.
| Gross Margin | 49.89% |
| Operating Margin | -22,111.82% |
| Pretax Margin | -21,786.08% |
| Profit Margin | -21,786.08% |
| EBITDA Margin | -21,986.23% |
| EBIT Margin | -22,087.23% |
| FCF Margin | -17,087.41% |
Dividends & Yields
Aspargo Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |